Biotech Vaults Back with help from Array Biopharma…Update-2…Not a lotta
Update-2...3:15p EDT.... Mixed day-new post after close, XBI down 0.64%, IBB down 0.94%,, Dow sell-off down 0.43%. ====== Update-1 5/22... Not much follow-through from yesterday but trade-able.A horrible news week with politics, tariffs, chips and China in headlines. Large Caps are favored:...
ASCO Rally Fizzles: The nascent rally in biotech stocks fades.Update-2
Update-2...NASDAQ Rally triggers biotechs-XBI up 2.3% to $82.63 just above 2019 support level.Administration eased Huawei blocks because of trade concerns. Update -1 ...11a EDT-Biotech Red Screen-Following NASDAQ. Risk-Off. The sell-off that started with Friday's reversal continued today in...
Bad Week in Biotech: Deciphering the Damage…Update-3 5/16 ASCO rally
Update-3 12:30 P EDT ASCO Rally seems too be kicking in.Green Screen! Update-2 5/15 10;45a EDT Gene therapy and mid-cap biopharma getting traction this am.XBI up 0.7% to $82.44. Update-1 5/14 3:30P EDT,Mid and small cap biotechs rally with NASDAQ, XBI up over 2%. Per our comments below...
Biotech Week Ending May 4: Choppy Action Persists-Risk Off…Update-3
Traders -look for a turnaround in small cap biopharma and medtech today. NAZ at 7890. 5/10 1:30p EDT....Well we know now that even biotech stocks are not immune to tariffs. Risk off. Major ETFS IBB at 104.5 and XBI near 84 are at intermediate support and off lows for the week. But despite a bad...
Biopharma Wrap-Up Q1 2019: Large Caps Lag Since August 2018
Biopharma Wrap-Up: Sideways to Neutral in Active Trading for Quarter Biopharma stocks ended the quarter in a snooze as investors took a wait and see attitude as earnings roll-out for large caps. The IBB was off 0.83% today to $106.42 and up 9% QTD. The XBI is still up 19.65% QTD but in a...